Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Mechanisms of Osteoblastic Bone Metastasis in Prostate Cancer: Role of Prostatic Acid Phosphatase.

Quiroz-Munoz M, Izadmehr S, Arumugam D, Wong B, Kirschenbaum A, Levine AC.

J Endocr Soc. 2019 Feb 1;3(3):655-664. doi: 10.1210/js.2018-00425. eCollection 2019 Mar 1. Review.

2.

Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer.

McClinch K, Avelar RA, Callejas D, Izadmehr S, Wiredja D, Perl A, Sangodkar J, Kastrinsky DB, Schlatzer D, Cooper M, Kiselar J, Stachnik A, Yao S, Hoon D, McQuaid D, Zaware N, Gong Y, Brautigan DL, Plymate SR, Sprenger CCT, Oh WK, Levine AC, Kirschenbaum A, Sfakianos JP, Sears R, DiFeo A, Ioannou Y, Ohlmeyer M, Narla G, Galsky MD.

Cancer Res. 2018 Apr 15;78(8):2065-2080. doi: 10.1158/0008-5472.CAN-17-0123. Epub 2018 Jan 22.

3.

Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases.

Kirschenbaum A, Izadmehr S, Yao S, O'Connor-Chapman KL, Huang A, Gregoriades EM, Yakar S, Levine AC.

Endocrinology. 2016 Dec;157(12):4526-4533. Epub 2016 Oct 26.

4.

Metastatic Malignant Melanoma to Urinary Bladder: A Potential Pitfall for High-Grade Urothelial Carcinoma.

Rishi A, Anderson TA, Kirschenbaum AM, Unger PD.

Int J Surg Pathol. 2014 Jun;22(4):347-51. doi: 10.1177/1066896913492199. Epub 2013 Jun 20.

PMID:
23794493
5.

Androgens up-regulate transcription of the Notch inhibitor Numb in C2C12 myoblasts via Wnt/β-catenin signaling to T cell factor elements in the Numb promoter.

Liu XH, Wu Y, Yao S, Levine AC, Kirschenbaum A, Collier L, Bauman WA, Cardozo CP.

J Biol Chem. 2013 Jun 21;288(25):17990-8. doi: 10.1074/jbc.M113.478487. Epub 2013 May 6.

6.

KLF6-SV1 drives breast cancer metastasis and is associated with poor survival.

Hatami R, Sieuwerts AM, Izadmehr S, Yao Z, Qiao RF, Papa L, Look MP, Smid M, Ohlssen J, Levine AC, Germain D, Burstein D, Kirschenbaum A, DiFeo A, Foekens JA, Narla G.

Sci Transl Med. 2013 Jan 23;5(169):169ra12. doi: 10.1126/scitranslmed.3004688.

7.

Nandrolone, an anabolic steroid, stabilizes Numb protein through inhibition of mdm2 in C2C12 myoblasts.

Liu XH, Yao S, Levine AC, Kirschenbaum A, Pan J, Wu Y, Qin W, Collier L, Bauman WA, Cardozo CP.

J Androl. 2012 Nov-Dec;33(6):1216-23. doi: 10.2164/jandrol.112.016428. Epub 2012 Jun 14.

PMID:
22700758
8.

Androgen deprivation therapy as primary treatment for prostate cancer.

Cannata DH, Kirschenbaum A, Levine AC.

J Clin Endocrinol Metab. 2012 Feb;97(2):360-5. doi: 10.1210/jc.2011-2353. Epub 2011 Dec 7. Review.

PMID:
22162475
9.

Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation.

Kirschenbaum A, Liu XH, Yao S, Leiter A, Levine AC.

Ann N Y Acad Sci. 2011 Nov;1237:64-70. doi: 10.1111/j.1749-6632.2011.06198.x.

PMID:
22082367
10.

Nandrolone reduces activation of Notch signaling in denervated muscle associated with increased Numb expression.

Liu XH, Yao S, Qiao RF, Levine AC, Kirschenbaum A, Pan J, Wu Y, Qin W, Bauman WA, Cardozo CP.

Biochem Biophys Res Commun. 2011 Oct 14;414(1):165-9. doi: 10.1016/j.bbrc.2011.09.048. Epub 2011 Sep 17.

PMID:
21945932
11.

Overview of prostate anatomy, histology, and pathology.

Lee CH, Akin-Olugbade O, Kirschenbaum A.

Endocrinol Metab Clin North Am. 2011 Sep;40(3):565-75, viii-ix. doi: 10.1016/j.ecl.2011.05.012. Review.

PMID:
21889721
12.

Prostaglandin E2 modulates components of the Wnt signaling system in bone and prostate cancer cells.

Liu XH, Kirschenbaum A, Weinstein BM, Zaidi M, Yao S, Levine AC.

Biochem Biophys Res Commun. 2010 Apr 9;394(3):715-20. doi: 10.1016/j.bbrc.2010.03.057. Epub 2010 Mar 17.

PMID:
20227393
13.

Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.

Xiong SD, Yu K, Liu XH, Yin LH, Kirschenbaum A, Yao S, Narla G, DiFeo A, Wu JB, Yuan Y, Ho SM, Lam YW, Levine AC.

Int J Cancer. 2009 Aug 15;125(4):774-82. doi: 10.1002/ijc.24325. Erratum in: Int J Cancer. 2009 Oct 15;125(8):1995.

14.

Urinary bladder adenocarcinoma arising in a spina bifida patient.

Bitar M, Mandel E, Kirschenbaum AM, Unger PD.

Ann Diagn Pathol. 2007 Dec;11(6):453-6. Epub 2007 Jul 24.

PMID:
18022132
15.

Concomitant secretion of glucocorticoid, androgens, and mineralocorticoid by an adrenocortical carcinoma: case report and review of literature.

Messer CK, Kirschenbaum A, New MI, Unger P, Gabrilove JL, Levine AC.

Endocr Pract. 2007 Jul-Aug;13(4):408-12. Review.

PMID:
17669719
16.

Androgens promote preosteoblast differentiation via activation of the canonical Wnt signaling pathway.

Liu XH, Kirschenbaum A, Yao S, Levine AC.

Ann N Y Acad Sci. 2007 Nov;1116:423-31. Epub 2007 Jul 23.

PMID:
17646262
17.

Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells.

Liu XH, Kirschenbaum A, Yao S, Liu G, Aaronson SA, Levine AC.

Cancer Res. 2007 Jun 15;67(12):5747-53.

18.

Mycobacterium marinum tenosynovitis in a patient on etanercept therapy for rheumatoid arthritis.

Chopra N, Kirschenbaum AE, Widman D.

J Clin Rheumatol. 2002 Oct;8(5):265-8.

PMID:
17041383
19.

The role of the interleukin-6/gp130 signaling pathway in bone metabolism.

Liu XH, Kirschenbaum A, Yao S, Levine AC.

Vitam Horm. 2006;74:341-55. Review. No abstract available.

PMID:
17027522
20.

Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system.

Liu XH, Kirschenbaum A, Yao S, Levine AC.

Ann N Y Acad Sci. 2006 Apr;1068:225-33.

PMID:
16831922
21.

Case and management of incidentalomas in patients with Von Hippel-Lindau disease.

O'Malley R, Chughtai B, Sukkarieh T, Kirschenbaum A, Naik R, Sawas A, Khan SA, Rehman J.

Urol Int. 2005;75(2):189-91.

PMID:
16123578
22.

Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones.

Kirschenbaum A, Liu XH, Yao S, Narla G, Friedman SL, Martignetti JA, Levine AC.

Carcinogenesis. 2006 Feb;27(2):216-24. Epub 2005 Aug 25.

PMID:
16123118
23.

Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.

Narla G, DiFeo A, Yao S, Banno A, Hod E, Reeves HL, Qiao RF, Camacho-Vanegas O, Levine A, Kirschenbaum A, Chan AM, Friedman SL, Martignetti JA.

Cancer Res. 2005 Jul 1;65(13):5761-8.

24.

Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury.

Kofman AV, Morgan G, Kirschenbaum A, Osbeck J, Hussain M, Swenson S, Theise ND.

Hepatology. 2005 Jun;41(6):1252-61.

PMID:
15880565
26.
27.

Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line.

Liu XH, Kirschenbaum A, Lu M, Yao S, Dosoretz A, Holland JF, Levine AC.

J Biol Chem. 2002 Dec 20;277(51):50081-6. Epub 2002 Oct 24.

28.

Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway.

Liu XH, Kirschenbaum A, Lu M, Yao S, Klausner A, Preston C, Holland JF, Levine AC.

Biochem Biophys Res Commun. 2002 Jan 11;290(1):249-55.

PMID:
11779161
29.

The role of cyclooxygenase-2 in prostate cancer.

Kirschenbaum A, Liu X, Yao S, Levine AC.

Urology. 2001 Aug;58(2 Suppl 1):127-31. Review.

PMID:
11502467
30.

Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate.

Kirschenbaum A, Klausner AP, Lee R, Unger P, Yao S, Liu XH, Levine AC.

Urology. 2000 Oct 1;56(4):671-6.

PMID:
11018637
31.

Immunohistochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the human fetal and adult male reproductive tracts.

Kirschenbaum A, Liotta DR, Yao S, Liu XH, Klausner AP, Unger P, Shapiro E, Leav I, Levine AC.

J Clin Endocrinol Metab. 2000 Sep;85(9):3436-41.

PMID:
10999846
32.

Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.

Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC.

J Urol. 2000 Sep;164(3 Pt 1):820-5.

PMID:
10953162
33.
34.

MUC1 Expression in Prostate Carcinoma: Correlation with Grade and Stage.

Kirschenbaum A, Itzkowitz SH, Wang JP, Yao S, Eliashvili M, Levine AC.

Mol Urol. 1999;3(3):163-168.

PMID:
10851319
35.

The organization of vocational rehabilitation: the structure of success.

Kirschenbaum A.

Int J Rehabil Res. 1999 Sep;22(3):215-25.

PMID:
10839675
36.

Well being, work environment and work accidents.

Kirschenbaum A, Oigenblick L, Goldberg AI.

Soc Sci Med. 2000 Mar;50(5):631-9.

PMID:
10658844
37.

Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts.

Levine AC, Liu XH, Greenberg PD, Eliashvili M, Schiff JD, Aaronson SA, Holland JF, Kirschenbaum A.

Endocrinology. 1998 Nov;139(11):4672-8.

PMID:
9794479
38.
39.

Glenohumeral pyarthrosis following acupuncture treatment.

Kirschenbaum AE, Rizzo C.

Orthopedics. 1997 Dec;20(12):1184-6. No abstract available.

PMID:
9415915
40.

Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumors.

Kirschenbaum A, Wang JP, Ren M, Schiff JD, Aaronson SA, Droller MJ, Ferrara N, Holland JF, Levine AC.

Urol Oncol. 1997 Jan-Feb;3(1):3-10.

PMID:
21227046
41.

The role of sex steroids in the pathogenesis and maintenance of benign prostatic hyperplasia.

Levine AC, Kirschenbaum A, Gabrilove JL.

Mt Sinai J Med. 1997 Jan;64(1):20-5.

PMID:
8997072
42.
43.

Lack of effect of a gonadotropin-releasing hormone agonist in a patient with prostate cancer and a gonadotroph adenoma.

Schuval BJ, Kirschenbaum A, Wolfe D, Post KD, Levine AC.

J Clin Endocrinol Metab. 1996 Feb;81(2):864. No abstract available.

PMID:
8636319
44.

Lack of correlation between prostate-specific antigen density and prostatic shrinkage in response to finasteride therapy.

Kirschenbaum A, Pacheco E, Schuval BJ, Levine AC.

World J Urol. 1996;14(6):360-2.

PMID:
8986036
45.

Immunohistochemical localization of steroid 5 alpha-reductase 2 in the human male fetal reproductive tract and adult prostate.

Levine AC, Wang JP, Ren M, Eliashvili E, Russell DW, Kirschenbaum A.

J Clin Endocrinol Metab. 1996 Jan;81(1):384-9.

PMID:
8550782
46.

Screening in the new environment of medicine: prostate cancer.

Kirschenbaum A.

Mt Sinai J Med. 1995 Sep;62(4):257-61. No abstract available.

PMID:
7565847
48.
49.

Primary renal carcinoid tumor.

Schlussel RN, Kirschenbaum AM, Levine A, Unger P.

Urology. 1993 Mar;41(3):295-7. Review.

PMID:
8442319
50.

The effect of dihydrotestosterone and culture conditions on proliferation of the human prostatic cancer cell line LNCaP.

Chen HZ, Kirschenbaum A, Mandeli J, Hollander VP.

Steroids. 1992 Jun;57(6):269-75.

PMID:
1440697

Supplemental Content

Loading ...
Support Center